AI and Autonomy Tempus AI buys Personalis to strengthen AI-driven cancer monitoring platform The acquisition targets a cancer monitoring market that the companies estimate could reach USD$20 billion Joseph Morton1 day ago
Medical and Pharmaceutical China’s Westlake University develops palm-sized lung cancer blood test It could surpass current liquid biopsy options after further evaluation Rowan DunneMay 27, 2026